Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 6 of about 4 companies and 2 funds for MARK HAHN�
Company Exchange Symbol Last price Quote change Market cap
Cempra Inc NASDAQ CEMP 33.61 +0.13 (0.39%) 1.47B
Cempra Inc. is a clinical-stage pharmaceutical company focused on developing differentiated antibiotics for the acute care and community settings to meet ...
Executive:
Mark W. Hahn
GlycoMimetics Inc NASDAQ GLYC 7.02 +0.03 (0.43%) 133.13M
GlycoMimetics, Inc. (GlycoMimetics) is a clinical-stage biotechnology company. The Company focuses on the discovery and development of glycomimetic drugs to ...
Executive:
Mark A Goldberg MD
Canamex Resources Corp CVE CSQ 0.0400 0.0000 (0.00%) 5.17M
Canamex Resources Corp. is a Canada-based exploration company. The Company is focused on its gold exploration project, Bruner Gold project, Nye County, ...
Executive:
Mark A. Billings
Cempra Holdings, LLC Private
Cempra Holdings isn't afraid of a little staph, or pneumonia for that matter. The company is in the clinical stages of developing antibiotics that treat ...
Executive:
Mark W. Hahn
Mutual Fund Symbol Nav Nav change
Principal Dynamic High Yield Explorer Fund Institutional Class Shares PDYIX 9.42 0.00 (0.00%)
The investment seeks to provide a high level of current income with an emphasis on managing volatility. Under normal circumstances, the fund invests at ...
Executive:
Mark P. Denkinger.
Principal Dynamic High Yield Explorer Fund Class A Shares PDYAX 9.40 0.00 (0.00%)
The investment seeks to provide a high level of current income with an emphasis on managing volatility. Under normal circumstances, the fund invests at ...
Executive:
Mark P. Denkinger.